Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Yumanity
Biotech
Kineta faces shutdown as private placement fails to show up
After a strategic review, small oncology biotech Kineta is conducting a corporate restructuring and reducing its workforce by 64%.
Annalee Armstrong
Feb 29, 2024 9:32am
Identifying 'gems': J&J gives insider look at dealmaking spree
May 15, 2023 5:00am
Top 10 game-changing biotech layoffs in H1
Jul 19, 2022 3:00am
Yumanity's end: J&J pays $26M for neuroscience assets
Jun 6, 2022 9:10am
Layoff 'wave' not letting up amid oversaturation of biotechs
Mar 28, 2022 10:05am
Yumanity to cut 60% of workforce by April, looking for buyers
Feb 17, 2022 10:53am
